ThermoGenesis Holdings (THMO) Receives $1.28M Conversion Notice from Boyalife

On March 15, 2024, ThermoGenesis Holdings (NASDAQ: THMO) received a conversion notice from Boyalife Group, Inc. (“Boyalife”) to convert $1,278,000 of the outstanding principal and $285,000 of the outstanding accrued interest for a total of $1,563,000 of the Second Amended and Restated Convertible Promissory Note issued by the Company to Boyalife on April 16, 2018, as amended by Amendment No 1 dated March 4, 2022, Amendment No 2 dated March 6, 2023 and Amendment No 3 dated January 5, 2024 (as amended, the “Note”). The conversion resulted in the issuance of 4,113,158 shares of the Company’s common stock at a conversion price of $0.38 per share. Immediately following the conversion, the outstanding principal and accrued interest of the Note was approximately $6,366,000, and the Company’s total outstanding shares were 7,952,780.

You May Also Be Interested In

• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
• SharonAI Holdings (SHAZ) files for 8.06M share offering by selling stockholders
• Getty Realty discloses separation terms for departing accounting officer